$21.03
1.678.63%
al cierre: -
$20.91
-0.12-0.58%
After hour: Apr 11, 7:59 PM EDT
ARK Genomic Revolution ETF (BATS: ARKG)
Ticker | Name | Share % | |
---|---|---|---|
TWST | Twist Bioscience Corp. | 8.93% | |
CDNA | Caredx | 4.40% | |
SM | Crispr Therapeutics Ag | 7.41% | |
RXRX | Recursion Pharmaceuticals, Inc. | 6.91% | |
IONS | Ionis Pharmaceuticals Inc | 4.88% | |
NTLA | Intellia Therapeutics | 4.74% | |
BEAM | Beam Therapeutics Inc | 3.91% | |
SDGR | Schrodinger, Inc. | 4.65% | |
ADPT | Adaptive Biotechnologies Corporation | 6.27% | |
TXG | 10X Genomics Inc | 3.61% | |
TEM | Tempus Pe | 8.47% | |
NTRA | Natera Inc | 5.95% | |
GH | Guardant Health Inc. | 6.26% |
Quote.FAQ.Answers.ETFs.etf-performance
Quote.FAQ.Answers.ETFs.expense-ratio
Quote.FAQ.Answers.ETFs.aum
ARKG sigue un estilo de inversión Small Cap Growth.
Las principales posiciones de ARKG incluyen: TWST (8.93%), CDNA (4.4%), SM (7.41%), RXRX (6.91%), IONS (4.88%). Estas representan las mayores posiciones en la cartera del ETF.
Los datos del volumen medio diario para ARKG no están disponibles actualmente.